These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7738213)

  • 21. [Renal tissue angiotensins during converting enzyme inhibition of angiotensin I in spontaneously hypertensive rat].
    Ingert C; Grima M; Michel B; Barthelmebs M; Imbs JL
    Arch Mal Coeur Vaiss; 1997 Aug; 90(8):1135-41. PubMed ID: 9404423
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Steady-state pharmacokinetics and pharmacodynamics of benazeprilat in spontaneously hypertensive rats (SHR) and Wistar-Kyoto (WKY) rats.
    LeRoy S; Berner B
    Pharm Res; 1991 Jul; 8(7):883-7. PubMed ID: 1924139
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of eight-day converting enzyme inhibition on ambulatory blood pressure recordings in normotensive volunteers.
    Bidiville J; Porchet M; Bussien JP; Nussberger J; Waeber B; Brunner HR
    Arch Int Pharmacodyn Ther; 1987 Jul; 288(1):109-19. PubMed ID: 2959228
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Arterial and endocrine effects of a combination of an angiotensin converting enzyme inhibitor and a vasodilator in normotensive healthy volunteers.
    Brunel P; Guyene TT; Howald H; Ménard J
    J Cardiovasc Pharmacol; 1991 Aug; 18(2):175-81. PubMed ID: 1717776
    [TBL] [Abstract][Full Text] [Related]  

  • 25. (Des-Asp1) angiotensin I: a study of its pressor and steroidogenic activities in conscious rats.
    Campbell WB; Schmitz JM; Itskovitz HD
    Endocrinology; 1977 Jan; 100(1):46-51. PubMed ID: 187407
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of angiotensin converting enzyme by SQ 14,225 in conscious rabbits.
    Murthy VS; Waldron TL; Goldberg ME; Vollmer RR
    Eur J Pharmacol; 1977 Dec; 46(3):207-12. PubMed ID: 201471
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of SQ 14,225, an orally active inhibitor of angiotensin-converting enzyme on blood pressure, heart rate and plasma renin activity of conscious normotensive dogs.
    Harris DN; Heran CL; Goldenberg HJ; High JP; Laffan RJ; Rubin B; Antonaccio MJ; Goldberg ME
    Eur J Pharmacol; 1978 Oct; 51(4):345-9. PubMed ID: 213295
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blood pressure control by the renin-angiotensin system in normotensive subjects. Assessment by angiotensin converting enzyme and renin inhibition.
    Kiowski W; Linder L; Kleinbloesem C; van Brummelen P; Bühler FR
    Circulation; 1992 Jan; 85(1):1-8. PubMed ID: 1728438
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apparently high plasma angiotensin II levels in patients with essential hypertension treated by converting enzyme inhibition.
    Boer P; Geyskes GG
    Scand J Clin Lab Invest; 1985 Feb; 45(1):77-81. PubMed ID: 2983412
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antihypertensive effects and arterial haemodynamic alterations during angiotensin converting enzyme inhibition.
    London GM; Pannier B; Vicaut E; Guérin AP; Marchais SJ; Safar ME; Cuche JL
    J Hypertens; 1996 Sep; 14(9):1139-46. PubMed ID: 8986916
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Renin-angiotensin system in two genetically normotensive strains of Lyon rats.
    Lantelme P; Lo M; Sassard J
    Am J Hypertens; 2000 Mar; 13(3):283-9. PubMed ID: 10777033
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The bladder angiotensin system in female rats: response to infusions of angiotensin I and the angiotensin converting enzyme inhibitor enalaprilat.
    Weaver-Osterholtz D; Reams G; De Vergel CF; Bauer JH
    J Urol; 2001 May; 165(5):1735-8. PubMed ID: 11342966
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of prolonged administration of the angiotensin converting enzyme inhibitor CGS 16617 in normotensive volunteers.
    Waeber G; Burnier M; Porchet M; Nussberger J; Waeber B; Brunner HR
    Eur J Clin Pharmacol; 1989; 36(6):587-91. PubMed ID: 2550244
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ACE (I/D) genotype as a predictor of the magnitude and duration of the response to an ACE inhibitor drug (enalaprilat) in humans.
    Ueda S; Meredith PA; Morton JJ; Connell JM; Elliott HL
    Circulation; 1998 Nov; 98(20):2148-53. PubMed ID: 9815869
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Central cardiovascular effects of SQ 14,225, an angiotensin-converting enzyme inhibitor in chloralose-anesthetized cats.
    Vollmer RR; Boccagno JA
    Eur J Pharmacol; 1977 Sep; 45(2):117-25. PubMed ID: 198216
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Maintenance of baseline angiotensin II potentiates insulin hypertension in rats.
    Keen HL; Brands MW; Smith MJ; Hall JE
    Hypertension; 1998 Feb; 31(2):637-42. PubMed ID: 9461234
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Maximally recommended doses of angiotensin-converting enzyme (ACE) inhibitors do not completely prevent ACE-mediated formation of angiotensin II in chronic heart failure.
    Jorde UP; Ennezat PV; Lisker J; Suryadevara V; Infeld J; Cukon S; Hammer A; Sonnenblick EH; Le Jemtel TH
    Circulation; 2000 Feb; 101(8):844-6. PubMed ID: 10694521
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Angiotensin converting enzyme (ACE) and non-ACE dependent angiotensin II generation in resistance arteries from patients with heart failure and coronary heart disease.
    Petrie MC; Padmanabhan N; McDonald JE; Hillier C; Connell JM; McMurray JJ
    J Am Coll Cardiol; 2001 Mar; 37(4):1056-61. PubMed ID: 11263608
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of combining an ACE inhibitor and an angiotensin II receptor blocker on plasma and kidney tissue angiotensin II levels.
    Komine N; Khang S; Wead LM; Blantz RC; Gabbai FB
    Am J Kidney Dis; 2002 Jan; 39(1):159-64. PubMed ID: 11774115
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of blood pressure and angiotensin responses to the renin inhibitor Ro 42-5892 and the angiotensin converting enzyme inhibitor enalapril in essential hypertension.
    van den Meiracker AH; Admiraal PJ; Derkx FH; Kleinbloesem C; Man in 't Veld AJ; van Brummelen P; Mulder P; Schalekamp MA
    J Hypertens; 1993 Aug; 11(8):831-8. PubMed ID: 8228207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.